IP Library Granted Patent US 7,338,770
Granted Patent B2
US 7,338,770 · App. 11/055,622 · Granted Mar 4, 2008

Human procalcitonin and the preparation and use thereof

Assignee: Dade Behring Marburg GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,338,770
App. No.
11/055,622
Granted
Mar 4, 2008
Kind
B2
Abstract

The invention relates to human procalcitonin and the preparation and use thereof. In particular, a process for preparing human procalcitonin is described wherein a gene coding for a polypeptide comprising the amino acid sequence of human procalcitonin is inserted into a vector; a host organism is transformed with this gene-containing vector; and the polypeptide expressed by the host organism is isolated. Furthermore the use of the polypeptides according to the invention, in particular as medicaments and diagnostic agents is described.

Claims (4)

1. A method for using an isolated recombinant polypeptide comprising an amino acid sequence SEQ ID NO: 8, wherein the polypeptide is associated with a solid phase and/or a reporter system component to detect an analyte comprising binding the polypeptide to the analyte and detecting the binding.

2. A method for using an isolated recombinant polypeptide comprising an amino acid sequence SEQ ID NO: 9, wherein the polypeptide is associated with a solid phase and/or a reporter system component to detect an analyte comprising binding the polypeptide to the analyte and detecting the binding.

3. The method according to claim 1 , wherein the analyte is an anti-procalcitonin antibody.

4. The method according to claim 2 , wherein the analyte is an anti-procalcitonin antibody.

Assignments (2)
SECURITY INTEREST Recorded Aug 5, 2021
From: QUANTUM CORPORATION; QUANTUM LTO HOLDINGS, LLC
To: BLUE TORCH FINANCE LLC, AS AGENT
Reel/Frame 057107/0001 →
CHANGE OF NAME Recorded Feb 26, 2009
From: DADE BEHRING MARBURG GMBH
To: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Reel/Frame 022309/0627 →
Priority Claims (3)
DE 199 62 434 · Dec 22, 1999 · national
DE 100 16 278 · Apr 3, 2000 · national
DE 100 27 954 · Jun 8, 2000 · national
Continuity (3)
Division 1039405800 · Mar 24, 2003
Division 0974237300 · Dec 22, 2000
Related Publication 20050186660A1 · Aug 25, 2005